Atos Medical Inc.

Atos Medical Inc., a foreign-owned medical device manufacturer headquartered in New Berlin, Wisconsin, supplies artificial larynges, voice prostheses, heat and moisture exchangers, and tracheostomy supplies to the Department of Veterans Affairs as a prime contractor, competing in full and open competition with no set-aside designations across its federal footprint.

Atos Medical operates exclusively as a prime contractor (100% of recent awards) across 1,778 federal awards spanning from 2005 to present, with a combined potential value of $24.4 million and $9.9 million in obligated dollars. The vendor specializes in laryngectomy care and voice rehabilitation products, with work concentrated under two primary indefinite delivery vehicles: an Indefinite Delivery Contract 36C79120D0001 ($900 thousand combined potential value across 48 task orders) awarded by VA VISN 19 in December 2019 for artificial larynges, and a GSA Federal Supply Schedule Medical Equipment and Supplies contract (FSS-65-II-A) with a $5 million ceiling awarded March 1, 2022 through February 28, 2027, which generated 3 task orders worth $1.2 million in combined potential value. A newly awarded single-award Indefinite Delivery Contract valued at $1.95 million with VA VISN 19 (awarded December 3, 2024, performance through December 2, 2026) procures digital, analog, and intra-oral artificial larynx devices with estimated annual quantities ranging from 30 to 270 devices per contract line item number. Representative delivery orders include a $646.3 thousand firm fixed-price order from VISN 17 in December 2025 for six line items of Provox supplies under the GSA Schedule, a $523.8 thousand order from VISN 17 in June 2026 for six Provox laryngectomy care and voice rehabilitation product line items, and monthly EXPRESS REPORT delivery orders from VISN 19 ranging from $8,128 to $36,714 per order for artificial larynges.

Customer concentration sits entirely within the Department of Veterans Affairs Veterans Health Administration. The top five VISNs by award count and potential value account for substantially all recent work: VISN 19 leads with 55 awards worth $10.3 million combined potential value, followed by VISN 17 with 20 awards totaling $5.4 million, VISN 12 with 7 awards worth $5.1 million, VISN 15 with 2 awards totaling $488 thousand, and VISN 22 with 5 awards worth $68 thousand. These five VISNs represent 88% of combined potential value across all customer agencies. The source data covers only 97 of the 1,778 total awards in the vendor's portfolio, indicating substantial volume in smaller delivery orders and routine replenishment contracts not individually listed.

Activity has remained relatively flat in recent years, with 12 awards in 2022, 13 in 2023, and 16 in 2024, declining to 6 awards in 2025 and 1 award in 2026 year-to-date. The recompete cliff is minimal, with only one award completion in the next twenty-four months carrying $524 thousand in combined potential value. Work is performed primarily at Atos Medical's New Berlin, Wisconsin headquarters, with some fulfillment originating from Sweden per the IDV contract summary. The vendor's award portfolio by NAICS code concentration reflects medical device merchant wholesaling (867 awards) and surgical and medical instrument manufacturing (280 awards), with PSC concentration in Medical and Surgical Instruments, Equipment, and Supplies (1,190 awards) and maintenance/repair/rebuild of medical equipment (329 awards). Atos Medical has maintained federal registration since at least 2005 and competes solely on commercial price lists without set-aside posture or teaming arrangements across its documented federal prime footprint.